AML: Expert Guidance on Current Standards and New Directions in Patient Care

In this program experts discuss how to identify patients using molecular and cytogenetic testing to optimally select recently approved agents to improve patient outcomes. Watch the on-demand Webcast download the slides from a dynamic CCO symposium in Orlando and access a downloadable summary resource.

Share

Program Content

Activities

Biomarkers and MRD in AML
When and How to Assess Genomic and Molecular Alterations in AML: Which Mutations Matter?
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2019

Expires: December 04, 2020

AML Targeted Agents
Available and Emerging Treatment Options in FLT3-Mutant and IDH-Mutant AML
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2019

Expires: December 04, 2020

Treating Newly Diagnosed AML
Overcoming Treatment Challenges With New Targeted Agents and Formulations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2019

Expires: December 04, 2020

Immunotherapy in AML
New Advances in Antibody–Drug Conjugates and Other Immunotherapeutic Agents
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2019

Expires: December 07, 2020

Activities

AML Resource Guide
2019 AML Treatment Algorithms and Key Ongoing Phase III Clinical Trials: A Clinician’s Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2019

Expires: December 07, 2020

Faculty

cover img faculity

Amir Fathi, MD

Assistant Professor of Medicine
Department of Medicine
Harvard Medical School
Division of Hematology/Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

cover img faculity

Jeffrey E. Lancet, MD

Senior Member & Professor
Chair,
 Department of Malignant Hematology
Moffitt Cancer Center
Tampa, Florida

cover img faculity

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Eunice S. Wang, MD

Chief, Leukemia and Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Actinium

Boston Biomedical

Jazz Pharmaceuticals, Inc.

Pfizer, Inc.

Partners

NCCN

ProCE Banner